17 results
DEF 14A
LTRN
Lantern Pharma Inc
9 Apr 21
Definitive proxy
11:30am
Nominees
Our Board currently consists of six (6) members, four (4) of whom are independent under the listing standards for independence of the NASDAQ … of a listed company’s board of directors. Our Board has undertaken a review of its composition, the composition of its committees and the independence of each
DRS
EX-3.1
LTRN
Lantern Pharma Inc
24 Jan 20
Draft registration statement
12:00am
understanding of the independence, or lack thereof, of such nominee.
(c) Other Stockholder Proposals. For all business other than director nominations … Access Stockholder Nominee is independent under the independence requirements, including the committee independence requirements, set forth in the listing
S-1
EX-3.1
gx030799tpb
16 Apr 20
IPO registration
3:32pm
DRS
pyqqbjx
24 Jan 20
Draft registration statement
12:00am
424B4
e9f u2t5u2xw0slly
15 Jan 21
Prospectus supplement with pricing info
5:24pm
S-1
ct920n3h3toba ms
16 Apr 20
IPO registration
3:32pm
424B4
8ixufl56zsd59iw a6w
12 Jun 20
Prospectus supplement with pricing info
7:49am
DRS
ir0z6lc1n49qod7g
16 Dec 20
Draft registration statement
12:00am
10-K
1d3dxuu1opfa
10 Mar 21
Annual report
4:07pm
- Prev
- 1
- Next